Keiichi Fujiwara, MD, PhD

home / authors / keiichi-fujiwara-md-phd

Articles

POINT: Is There Still a Role for Intraperitoneal Platinum Therapy in Ovarian Cancer?

February 15th 2018

Intraperitoneal (IP) chemotherapy is a reasonable treatment approach for ovarian cancer because it can directly expose the surface tissues to which the cancer has disseminated to an extremely high concentration of the chemotherapy drug.

Use of IP Chemotherapy in Ovarian Cancer: The Critical Questions

Edward L. Trimble, MD, PhD;Keiichi Fujiwara, MD, PhD;Christian Marth, MD, PhD;Jeffrey S. Abrams, MD

February 21st 2011

The article by Dr. Echarri Gonzalez and her colleagues regarding intraperitoneal (IP) chemotherapy for women with epithelial ovarian cancer provides a comprehensive yet practical review of the critical questions surrounding the use of IP chemotherapy.